A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation studyJesse J. Swen, Roelof Bosch, Stefan Böhringer et al.|The Lancet|2023Cited by 508
Economic evaluation in psychiatric pharmacogenomics: a systematic reviewKariofyllis Karamperis, Christina Mitropoulou, Maria Koromina et al.|The Pharmacogenomics Journal|2021Cited by 59
Clinical implementation of preemptive pharmacogenomics in psychiatryΜαρία Σκώκου, Athanassios Vozikis, Kariofyllis Karamperis et al.|EBioMedicine|2024Cited by 56